Marilee Boerger v. HHS - Influenza, Guillain-Barré syndrome (2023)
Case summary [AI summaries can sometimes make mistakes]
Marilee Boerger filed a claim under the National Vaccine Injury Compensation Program alleging that the influenza vaccine she received on September 27, 2016, and/or the Tdap vaccine she received on November 20, 2016, caused her to develop Guillain-Barré syndrome (GBS). Both vaccines are listed on the Vaccine Injury Table.
The parties filed a stipulation on January 11, 2022, and the court adopted it as its decision, awarding compensation. Subsequently, on June 9, 2022, Ms.
Boerger filed a motion for attorneys' fees and costs. The court reviewed the request for reasonableness, applying the lodestar approach.
After adjustments for hourly rates and billing practices, the court awarded a total of $41,276.95, comprising $27,562.90 in attorneys' fees and $13,714.05 in attorneys' costs, payable to her counsel.
Source PDFs
USCOURTS-cofc-1_18-vv-00130